Tetraphase Pharmaceuticals, Inc. (TTPH) relating to its sale to AcelRx Pharmaceuticals, Inc. Under the terms of the agreement, each share of Tetraphase common stock will be converted into the right to receive 0.6303 of AcelRx common stock for each Tetraphase common stock owned.